PUBLIC CONTRACT · 2025
Medic. Anacinra 100 MG / Carfilzomib 60 MG / Nintedanib 150 MG
- Contract value
- €142,281.73
- Signed on
- 18 November 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 12027303PUBLISHED SUBJECT
41/5201/2025 - Medic. Anacinra 100 MG / Carfilzomib 60 MG / Nintedanib 150 MG
Parties involved
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- PT150 - Algarve
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- PROFARIN · Tax ID 500223238
- Awardee
- AMGEN BIOFARMACEUTICA, LDA · Tax ID 502942959
- Awardee
- Boehringer Ingelheim Portugal, Lda · Tax ID 500293023
Values and timeline
- Contract price
- €142,281.73
- Procedure base price
- €142,281.73
- Total effective price
- Not reported on Portal BASE
- Publication date
- 9 December 2025
- Award date
- 18 November 2025
- Signing date
- 18 November 2025
- Performance period
- 62 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- 491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 8119453
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.